Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra

被引:20
作者
Joshi, N. [1 ]
Rolheiser, T. M. [2 ]
Fisk, J. D. [3 ]
McKelvey, J. R. [4 ]
Schoffer, K. [4 ]
Phillips, G. [5 ]
Armstrong, M. [6 ]
Khan, M. N. [7 ]
Leslie, R. A. [8 ]
Rusak, B. [2 ,9 ]
Robertson, H. A. [2 ,4 ,10 ]
Good, K. P. [2 ,9 ]
机构
[1] IWK Hosp, Dept Psychiat, Halifax, NS, Canada
[2] Dalhousie Univ, Dept Psychiat, 4064 AJLB,5909 Vet Mem Lane, Halifax, NS, Canada
[3] Nova Scotia Hlth Author, Dept Psychol, Halifax, NS, Canada
[4] Nova Scotia Hlth Author, Dept Med, Div Neurol, Halifax, NS, Canada
[5] Nova Scotia Hlth Author, Dept Med, Div Respirol, Halifax, NS, Canada
[6] Dalhousie Univ, Fac Med, Halifax, NS, Canada
[7] IWK Hosp, Dept Radiol, Halifax, NS, Canada
[8] Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada
[9] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada
[10] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada
基金
加拿大健康研究院;
关键词
Parkinson's; Olfaction; Diffusion tensor imaging; Anterior olfactory structures; Substantia nigra; ALPHA-SYNUCLEIN; BULBUS VOLUME; WHITE-MATTER; GRAY-MATTER; FREE-WATER; DYSFUNCTION; ASYMMETRY; PATHOLOGY; ONSET; SCHIZOPHRENIA;
D O I
10.1007/s00415-017-8555-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a progressive neurological disorder characterized by motor symptoms as well as severe deficits in olfactory function and microstructural changes in olfactory brain regions. Because of the evidence of asymmetric neuropathological features in early-stage PD, we examined whether lateralized microstructural changes occur in olfactory brain regions and the substantia nigra in a group of early-stage PD patients. Using diffusion tensor imaging (DTI) and the University of Pennsylvania Smell Identification Test (UPSIT), we assessed 24 early-stage PD patients (Hoehn and Yahr stage 1 or 2) and 26 healthy controls (HC). We used DTI and a region of interest (ROI) approach to study the microstructure of the left and right anterior olfactory structures (AOS; comprising the olfactory bulbs and anterior end of the olfactory tracts) and the substantia nigra (SN). PD patients had reduced UPSIT scores relative to HC and showed increased mean diffusivity (MD) in the SN, with no lateralized differences. Significant group differences in fractional anisotropy (FA) and MD were seen in the AOS, but these differences were restricted to the right side and were not associated with the primary side of motor symptoms amongst PD patients. No associations were observed between lateralized motor impairment and lateralized microstructural changes in AOS. Impaired olfaction and microstructural changes in AOS are useful for early identification of PD but asymmetries in AOS microstructure seem unrelated to the laterality of PD motor symptoms.
引用
收藏
页码:1497 / 1505
页数:9
相关论文
共 57 条
  • [1] Altinayar S, 2014, EUR REV MED PHARMACO, V18, P3659
  • [2] Alpha-Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari
    Stewart, Tessandra
    Zhang, Jing
    [J]. BRAIN PATHOLOGY, 2016, 26 (03) : 410 - 418
  • [3] Olfactory Deficits and Amyloid-β Burden in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Aging: A PiB PET Study
    Bahar-Fuchs, Alex
    Chetelat, Gael
    Villemagne, Victor L.
    Moss, Simon
    Pike, Kerryn
    Masters, Colin L.
    Rowe, Christopher
    Savage, Greg
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (04) : 1081 - 1087
  • [4] Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI
    Benedetti, B
    Charil, A
    Rovaris, M
    Judica, E
    Valsasina, P
    Sormani, MP
    Filippi, M
    [J]. NEUROLOGY, 2006, 66 (04) : 535 - 539
  • [5] MDS research criteria for prodromal Parkinson's disease
    Berg, Daniela
    Postuma, Ronald B.
    Adler, Charles H.
    Bloem, Bastiaan R.
    Chan, Piu
    Dubois, Bruno
    Gasser, Thomas
    Goetz, Christopher G.
    Halliday, Glenda
    Joseph, Lawrence
    Lang, Anthony E.
    Liepelt-Scarfone, Inga
    Litvan, Irene
    Marek, Kenneth
    Obeso, Jose
    Oertel, Wolfgang
    Olanow, C. Warren
    Poewe, Werner
    Stern, Matthew
    Deuschl, Guenther
    [J]. MOVEMENT DISORDERS, 2015, 30 (12) : 1600 - 1609
  • [6] Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
    Berg, Daniela
    Postuma, Ronald B.
    Bloem, Bastiaan
    Chan, Piu
    Dubois, Bruno
    Gasser, Thomas
    Goetz, Christopher G.
    Halliday, Glenda M.
    Hardy, John
    Lang, Anthony E.
    Litvan, Irene
    Marek, Kenneth
    Obeso, Jose
    Oertel, Wolfgang
    Olanow, C. Warren
    Poewe, Werner
    Stern, Matthew
    Deuschl, Guenther
    [J]. MOVEMENT DISORDERS, 2014, 29 (04) : 454 - 462
  • [7] Stages in the development of Parkinson's disease-related pathology
    Braak, H
    Ghebremedhin, E
    Rüb, U
    Bratzke, H
    Del Tredici, K
    [J]. CELL AND TISSUE RESEARCH, 2004, 318 (01) : 121 - 134
  • [8] Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease
    Braak, H
    Braak, E
    Bohl, J
    Reintjes, R
    [J]. NEUROSCIENCE LETTERS, 1996, 210 (02) : 87 - 90
  • [9] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [10] Stanley Fahn Lecture 2005:: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
    Braak, Heiko
    Bohl, Juergen R.
    Muller, Christian M.
    Rub, Udo
    de Vos, Rob A. I.
    Del Tredici, Kelly
    [J]. MOVEMENT DISORDERS, 2006, 21 (12) : 2042 - 2051